HIV Infection

Although it is well known that patients with HIV have higher rates of incident heart failure and worse outcomes after an event, the role of NT-proBNP concentrations has not been explored. New research...

Researchers investigated the impact of frailty on morbidity and mortality among the aging population with and without HIV.

The Centers for Disease Control and Prevention has released guidance on what to consider when evaluating adolescents for pre-exposure prophylaxis for the prevention of HIV.

The National Institutes of Health has published guidelines for the treatment of COVID-19 that will be updated regularly as new data emerge.

Regenerating islet-derived protein 3α is a gut damage marker in inflammatory bowel diseases. Because people with HIV who are taking antiretroviral therapy often present with altered gut microbiota,...

Follicular helper T cells are well-known key HIV-1 reservoirs, but are the cells reservoirs for HIV-2 infection as well? A new study investigated.

Because diastolic dysfunction is common among individuals with HIV, authors of the CHART study aimed to evaluate the cardiovascular effects of dysfunction among patients receiving antiretroviral therapy. ...

By analyzing results of the multi-cohort Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study, researchers determined whether contemporary protease inhibitors have similar effects on chronic...

In a new study, the researchers aimed to compare antibody titers to HPV with the rate of abnormal cytology between perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.

The FDA has approved a new option for HIV-1 pre-exposure prophylaxis to reduce HIV-1 infection risk from sex, excluding in those who have receptive vaginal sex.